Remove Big Data Remove Business Development Remove Research
article thumbnail

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

Attendees will learn more about how an SCA was used at the design and execution phases in a recent study of new treatments for relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) and will also receive an eBook ‘How to harness the potential of AI and real-world data for clinical research’. About the panel.

article thumbnail

SMi’s 3rd Annual AI in Drug Discovery Conference

pharmaphorum

AI in drug discovery is becoming an integral part of the research and development area of treating diseases with more companies incorporating ‘Big Data’ and data scientists within their R&D teams. Discuss the impact of big data and how it applies to AI drug discovery within Pharma.

Drugs 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Analysis, and Test & Measurement Equipment Companies for the Pharmaceutical Industry

Pharmaceutical Technology

Additional solutions include compression and friability testers, spectrophotometers, digital multimeters (DMMs), field measuring equipment, recorders, data loggers, resistance meters, power meters, signal generators, calibrators, probes, sensors, precision balances, and grips and fixtures.

Engineer 130
article thumbnail

Empowering rare disease patient advocacy organisations with data

pharmaphorum

Komodo Health’s president and co-founder, Web Sun, tells us about his company’s new partnership with the Chan Zuckerberg Initiative (CZI) to improve early diagnosis and advance research of rare diseases by providing CZI’s Rare as One Network healthcare data and software. Web Sun is co-founder and president at Komodo Health.

article thumbnail

Using technology to reassess the clinical trial landscape

pharmaphorum

AppliedVR and Komodo Health will perform several health economic outcome research studies using a method Sackman says will allow the companies to shape the trials’ speed, quality, and design. Researchers will also evaluate the physical function, both subjective, through the traditional pain scores and patient-reported outcomes.

article thumbnail

Kiromic Announces the Filing of Key European Patents for Its Chimeric PD-1 (chPD1) Target

The Pharma Data

Barber is an associate professor of biology and director of the Office of Student Research. Her research focuses on determining the role costimulatory domains play in enhancing chimeric T-cell activity and the creation and testing of the chPD1 receptor as a therapy for multiple types of cancer. Dr. Barber is a tumor immunologist.

In-Vivo 40
article thumbnail

Laboratory services poised for the digital revolution

Pharmaceutical Technology

Meanwhile, decentralisation and the Big Data revolution are transforming the way researchers run clinical trials, and previously untapped geographies are emerging as new hubs for future research. Translating Big Data into results Big Data is another cornerstone of the digital revolution.